Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection

Abstract

The combined therapy with ursodeoxycholic acid and glycyrrhizin is safe and effective in improving liver-specific enzyme abnormalities, and may be an alternative to interferon in chronic hepatitis C virus infection, especially for interferon-resistant or unstable patients.